--- title: "IGF-DES | PepTracker Pro" description: "A truncated form of IGF-1 with high potency and rapid local activity at the site of administration." lang: en json-ld: | [ { "@context": "https://schema.org", "@type": "Organization", "name": "PepTracker Pro", "url": "https://peptrackerpro.com", "logo": "https://peptrackerpro.com/favicon.png", "description": "Evidence-based educational resource dedicated to improving peptide research literacy.", "contactPoint": { "@type": "ContactPoint", "email": "hello@peptrackerpro.com", "contactType": "customer support" }, "sameAs": [] }, { "@context": "https://schema.org", "@type": "MedicalWebPage", "name": "IGF-DES", "description": "A truncated form of IGF-1 with high potency and rapid local activity at the site of administration.", "url": "https://peptrackerpro.com/peptides/igf-des", "lastReviewed": "2026-05-27", "reviewedBy": { "@type": "Organization", "name": "PepTracker Pro Research Team", "url": "https://peptrackerpro.com" }, "isPartOf": { "@type": "WebSite", "name": "PepTracker Pro", "url": "https://peptrackerpro.com" } }, { "@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://peptrackerpro.com" }, { "@type": "ListItem", "position": 2, "name": "Peptides", "item": "https://peptrackerpro.com/peptides" }, { "@type": "ListItem", "position": 3, "name": "IGF-DES", "item": "https://peptrackerpro.com/peptides/igf-des" } ] }, { "@context": "https://schema.org", "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "People researching IGF-1 variants?", "acceptedAnswer": { "@type": "Answer", "text": "IGF-DES is a research peptide studied in preclinical models. A truncated form of IGF-1 with high potency and rapid local activity at the site of administration." } }, { "@type": "Question", "name": "Those studying localized tissue growth?", "acceptedAnswer": { "@type": "Answer", "text": "IGF-DES is a research peptide studied in preclinical models. A truncated form of IGF-1 with high potency and rapid local activity at the site of administration." } }, { "@type": "Question", "name": "Individuals comparing IGF-1 LR3 vs IGF-DES?", "acceptedAnswer": { "@type": "Answer", "text": "IGF-DES is a research peptide studied in preclinical models. A truncated form of IGF-1 with high potency and rapid local activity at the site of administration." } } ] } ] --- [Skip to main content](#main) **Educational information only.** This site does not provide medical advice. [Read full disclaimer](/disclaimer) [PepTracker Pro](/) [Home](/)[Peptides](/peptides)[Compare](/compare)[Glossary](/glossary)[Blog](/blog)[Calculators](/calculators)[Start Here](/start) [Open the App](https://app.peptrackerpro.com) [Peptides](/peptides)/ IGF-DES **Research-only content.** This page is for educational purposes and does not constitute medical advice. [Read full disclaimer →](/research-disclaimer) # IGF-DES Low Evidence A truncated form of IGF-1 with high potency and rapid local activity at the site of administration. Aliases Des(1-3) IGF-1 +1 more Evidence Low Evidence Last Updated 2026-05-27 Reading Time 2 min ## Table of Contents 1. [What It Is](#what-it-is) 2. [Why Researchers Study It](#why-researchers-study) 3. [Proposed Mechanisms](#proposed-mechanisms) 4. [Evidence Snapshot](#evidence-snapshot) 5. [Commonly Discussed Benefits](#benefits) 6. [Safety & Cautions](#safety) 7. [Comparisons](#comparisons) 8. [Calculator Tools](#calculator) 9. [Citations](#citations) ## What It Is IGF-DES (Des(1-3) IGF-1) is a truncated variant of insulin-like growth factor-1 missing the first three N-terminal amino acids (Gly-Pro-Glu). This truncation virtually eliminates binding to IGF-binding proteins (IGFBPs), making IGF-DES the most potent form of IGF-1 available in terms of free bioactivity. Without IGFBP regulation, IGF-DES exhibits approximately 10× greater potency than native IGF-1 in cell proliferation assays and has a very short half-life (approximately 20–30 minutes), producing rapid but transient IGF-1R activation. IGF-DES was originally identified as a naturally occurring variant in human brain tissue, where it is thought to act in an autocrine/paracrine fashion. Its extreme potency and lack of IGFBP buffering make it particularly high-risk from a safety perspective — unregulated IGF-1R signaling promotes cell proliferation pathways implicated in tumor growth and progression. Research applications are primarily limited to in vitro cell biology and tissue engineering where precise, short-duration IGF-1R stimulation is needed. IGF-DES has no clinical trial history, is classified as prohibited by WADA, and is not FDA-approved for any indication. Also known as: Des(1-3) IGF-1, IGF-1 DES ## Why Researchers Study It Des(1-3) IGF-1 lacks the first three amino acids of native IGF-1, which eliminates binding to IGF-binding proteins entirely. This results in dramatically increased bioactivity at the IGF-1 receptor, making it a potent research tool for studying maximal IGF-1 receptor activation and its downstream effects on cell proliferation. ## Proposed Mechanisms - Binds IGF-1 receptor with full affinity but cannot be sequestered by IGF-binding proteins - Approximately 10x more potent than native IGF-1 at receptor activation - Stimulates rapid cell proliferation and protein synthesis - Very short half-life concentrates activity at local injection site ## Evidence Snapshot Low Evidence Low Medium High ## Commonly Discussed Benefits [Muscle Growth](/benefits/muscle-growth)[Recovery](/benefits/recovery) Researching IGF-DES ? Track it, set reminders, and keep notes in the free app. [Track in App](https://app.peptrackerpro.com/?add=igf-des) ## Safety & Cautions - Extremely potent growth factor - Theoretical concerns about uncontrolled cell proliferation - Very short half-life requires precise administration - Not FDA-approved; limited human safety data ## Comparisons See how IGF-DES compares to related peptides: [IGF-DES vs CJC-1295](/compare/igf-des-vs-cjc-1295) [IGF-DES vs IGF-1 LR3](/compare/igf-des-vs-igf-1-lr3) [IGF-DES vs Ipamorelin](/compare/igf-des-vs-ipamorelin) [IGF-DES vs PEG-MGF](/compare/igf-des-vs-peg-mgf) ## Calculator Tools Use our research tools to explore dosing and reconstitution data: [Reconstitution Calculator](/calculators) ## Citations 1. \[1\] Ballard FJ. et al. — Des(1-3)IGF-I: a truncated form of insulin-like growth factor-I. Int J Biochem Cell Biol. 1996 [PubMed](https://pubmed.ncbi.nlm.nih.gov/) ### Keep researching in the app - Log IGF-DES to your private tracker - Set a dosing reminder - Compare it side-by-side with your stack [Open PepTracker Pro Free](https://app.peptrackerpro.com/?add=igf-des) [Browse more peptides](/peptides) ## Related Peptides ### CJC-1295 Medium Evidence A growth hormone releasing hormone analog studied for stimulating growth hormone secretion. [Muscle Growth](/benefits/muscle-growth)[Fat Loss](/benefits/fat-loss)[Recovery](/benefits/recovery)[Sleep](/benefits/sleep)+1 more [View Details](/peptides/cjc-1295) [\+ Compare](/compare?select=cjc-1295)[](https://app.peptrackerpro.com/?add=cjc-1295) ### IGF-1 LR3 Medium Evidence A modified form of IGF-1 with extended half-life, studied for muscle growth and tissue development. [Muscle Growth](/benefits/muscle-growth)[Recovery](/benefits/recovery)[Fat Loss](/benefits/fat-loss) [View Details](/peptides/igf-1-lr3) [\+ Compare](/compare?select=igf-1-lr3)[](https://app.peptrackerpro.com/?add=igf-1-lr3) ### Ipamorelin Medium Evidence A selective growth hormone secretagogue studied for targeted GH release with fewer side effects than other GH peptides. [Muscle Growth](/benefits/muscle-growth)[Fat Loss](/benefits/fat-loss)[Recovery](/benefits/recovery)[Sleep](/benefits/sleep)+1 more [View Details](/peptides/ipamorelin) [\+ Compare](/compare?select=ipamorelin)[](https://app.peptrackerpro.com/?add=ipamorelin) ### PEG-MGF Low Evidence A PEGylated splice variant of IGF-1 studied for muscle repair and satellite cell activation, with an extended half-life compared to native MGF. [Muscle Growth](/benefits/muscle-growth)[Recovery](/benefits/recovery)[Wound Healing](/benefits/wound-healing) [View Details](/peptides/peg-mgf) [\+ Compare](/compare?select=peg-mgf)[](https://app.peptrackerpro.com/?add=peg-mgf) [PepTracker Pro](/) Educational peptide information and research tracking tools. Not medical advice. #### Explore - [Peptide Directory](/peptides) - [Compare Peptides](/compare) - [Glossary](/glossary) - [Benefits](/benefits/sleep) #### Learn - [Blog](/blog) - [Calculators](/calculators) - [Start Here](/start) - [About](/about) #### Legal - [Editorial Policy](/editorial-policy) - [Research Disclaimer](/research-disclaimer) - [Disclaimer](/disclaimer) - [Privacy Policy](/privacy) - [Terms of Service](/terms) - [Contact](/contact) © 2026 PepTracker Pro. Educational purposes only. Not medical advice. Always consult a licensed healthcare provider.